Low Carbohydrate Diets in Cancer Therapeutics: Current Evidence

Low carbohydrate diets have a promising mechanistic rationale in the treatment of cancer with favorable preclinical data. The strongest data suggest synergistic effects of dietary interventions with traditional cancer therapies. Recent prospective clinical trials suggest that low carbohydrate diets are safely and feasibly added within a busy oncology clinic, with hopeful additive effects in treatment enhancement.

Automated summary

Low carbohydrate diets show promising potential in cancer treatment, with synergistic effects when combined with traditional therapies. Recent clinical trials indicate that adding low carbohydrate diets to oncology clinics is safe and feasible, with potential for enhancing treatment outcomes.